AbbVie Inc - Total Cashflows From Financing Activities

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cashflows-From-Financing-Activities" stands at -15.42 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

AbbVie Inc's third quarter result of -4.59 Billion USD for the item "Total Cashflows From Financing Activities" represents a decrease of -69.37 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of -4.59 Billion USD for the item "Total Cashflows From Financing Activities" represents a decrease of -49.41 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of -15.42 Billion USD for the item "Total Cashflows From Financing Activities" represents a decrease of -10.92 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -12.62 Billion United States Dollars compared to the value the year prior.
The 1 year change is -12.62 Billion United States Dollars.
The 3 year change is 6.09 Billion United States Dollars.
The 5 year change is -34.22 Billion United States Dollars.
The 10 year change is -22.72 Billion United States Dollars.

The Serie's long term average value is -6.42 Billion United States Dollars. It's latest available value, on 09/30/2025, is -9.00 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is +9.84 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2020, to it's latest available value, on 09/30/2025, is -37.09 Billion.